Boston Cancer Group is a clinical research site located in Memphis, Tennessee, United States 38119.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
Boston Cancer Group has participated in 3 clinical trials.
Therapeutic areas: Leukemia, Head and Neck Cancer, Lung Cancer.
Sponsors: Maxim Pharmaceuticals, Matrix Pharmaceutical, Spectrum Pharmaceuticals, Inc.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Memphis
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Boston Cancer Group has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Boston Cancer Group has 3 clinical trials on record. Their work covers Leukemia, Head and Neck Cancer, Lung Cancer.
Boston Cancer Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.